Subgroup-specific immune and stromal microenvironment in medulloblastoma
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Knowledge on immune and stromal cells in medulloblastoma microenvironment is still limited as previous work was frequently restricted by low sample size and the lack of molecular subgroup information. We characterized 10 microenvironment cell populations as well as PD-L1 from gene expression in 1422 brain tumors and 763 medulloblastomas. All in all, medulloblastomas showed low expression of immune markers. Still, there were substantial differences with a clustering of medulloblastoma subgroups according to their microenvironment profile. Specifically, SHH medulloblastomas displayed strong signatures of fibroblasts, T cells and macrophages, while markers of cytotoxic lymphocytes were enriched in Group 4 tumors. PD-L1 gene expression appeared to be relatively high in single SHH and WNT cases but was undetectable by immunohistochemistry. In addition, two diverse immuno-stromal patterns were identified, indicating distinct types of local tumor immunosuppression, which were primarily controlled by either macrophage and regulatory T cell-mediated mechanisms or immunosuppressive cytokines and checkpoints, respectively. None of the immune cell signatures had an independent prognostic value in the present dataset after multiple testing correction. These results suggest a mild, but subgroup-specific infiltration of immune cells in medulloblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activating mutations in the Wnt/β-catenin pathway can also induce resistance to ICB through altering the expression of PD-L1 and PD-L2 in a broad group of tumors such as melanoma, breast cancer, adenoid cystic carcinoma, and medulloblastoma (Bockmayr et al., 2018; Castagnoli et al., 2019).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Bockmayr et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
(2008) · Journal of Machine Learning Research · Cited by 33,051
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“CEL files) were downloaded from Gene Expression Omnibus (GEO).(52) For the pancancer analysis, 18 datasets covering 8 different tumors entities measured on the Affymetrix Human Genome U133 Plus 2.”
MethodRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 1×
“This suggests that the tumor either actively modulates the immune response or simply has little immunogenicity as is suggested by the relatively low mutational burden.(38) However, a recent study also demonstrated some form of systemic immune suppression present in medulloblastoma with lower lymphocyte counts and a hi…”
Backgroundaffy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 1×
“Tumor-infiltrating immune cells, principally lymphocytes, have been shown to be of prognostic relevance and predictive for response to chemotherapy in various solid tumors.(11,12) In particular, extensive research has been performed on tumor immunology in glioblastoma(13,14) and the potential for immunotherapy has bee…”
BackgroundBecht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,685
Research works printed but not linked: 5
- Boussiotis VA, 2017, Oncogene, 1
- Griesinger AM, 2013, J Immunol Baltim Md, 191, 4880
- 10.1080/2162402x.2017 · doi:10.1080/2162402x.2017
- 10.1016/j.ccell.2016.03.002 · DOI · Paper page
- R Core Team, 2016, R: A language and environment for statistical computing [Internet]
Cited by
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Northcott, P. A., Robinson, G. W., Kratz, C. P., Mabbott, D. J., Pomeroy, S. L., Clifford, S. C., Rutkowski, S., Ellison, D. W., Malkin, D., Taylor, M. D., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0063-6 · Cited by 649
Self-citationGrabovska, Y., Mackay, A., O’Hare, P., Crosier, S., Finetti, M., Schwalbe, E. C., Pickles, J. C., Fairchild, A. R., Avery, A., Cockle, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18070-y · Cited by 213
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
Klauschen, F., Müller, K.-R., Binder, A., Bockmayr, M., Hägele, M., Seegerer, P., Wienert, S., Pruneri, G., de Maria, S., Badve, S., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.001 · Cited by 168
Self-citationOpenPBTA: The Open Pediatric Brain Tumor Atlas
Shapiro, J. A., Gaonkar, K. S., Spielman, S. J., Savonen, C., Bethell, C. J., Jin, R., Rathi, K. S., Zhu, Y., Egolf, L. E., Farrow, B., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100340 · Cited by 87
Metadata
- Authors
- Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Schüller, Ulrich
- ORCID
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2018-05-24
- Volume
- 7
- Issue
- 9
- Pages
- e1462430
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- PMC
- PMC6140816
- OpenAlex
- W2804306812
- Cited by
- 121
- References
- 54
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 20 · 2023: 19 · 2022: 16 · 2021: 17 · 2020: 13 · 2019: 9 · 2018: 1
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- OncoImmunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- medulloblastoma, tumor microenvironment, tumor stroma, PD-L1, SHH medulloblastoma, Group 4 medulloblastoma, tumor-infiltrating immune cells, tumor-associated macrophages, regulatory T cells, fibroblasts, tumor immunosuppression, immune checkpoint, prognostic factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subgroup-specific immune and stromal microenvironment in medulloblastoma. https://app.cochat.ai/papers/10.1080/2162402x.2018.1462430
- The paper
- Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U. (2018). Subgroup-specific immune and stromal microenvironment in medulloblastoma. OncoImmunology. https://doi.org/10.1080/2162402x.2018.1462430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.